Evotec AG Stock
The Evotec AG stock is trending slightly upwards today, with an increase of €0.060 (0.140%) compared to yesterday's price.
With 22 Buy predictions and 1 Sell predictions Evotec AG is one of the favorites of our community.
On the other hand, the target price of €42.00 is below the current price of €43.62 for Evotec AG, so the potential is actually -3.714%.
Our community identified positive and negative aspects for Evotec AG stock for the coming years. 5 users see the criterium "Revenue growth" as a plus for the Evotec AG stock. On the other hand our users think that "Balance Sheet Risk" could be a problem in the future.
Pros and Cons of Evotec AG in the next few years
Pros
5
Revenue growth >5% per year expected
5
Could be worthwhile Investment >10% per year
3
Medium risks for its business
Cons
1
Risky balance sheet
Performance of Evotec AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evotec AG | 0.140% | 7.127% | -1.719% | 86.518% | 44.127% | 150.447% | 757.820% |
| MorphoSys AG | 0.900% | 0.651% | -7.619% | -58.842% | -58.772% | -54.918% | -7.464% |
| Mirati Therapeutics Inc. | -1.180% | 2.711% | -0.371% | -10.752% | -18.031% | - | - |
| Sage Therapeutics Inc. | 2.050% | -12.017% | -12.484% | -41.681% | -51.308% | - | - |
Comments
Other discussions about Evotec AG Stock
Trading Evotec AG
Trading Evotec AG
